Abstract. The pattern of expression of the protx2(I) collagen gene is highly tissue specific in adult mice and shows its strongest expression in bones, tendons, and skin. Transgenic mice were generated harboring promoter fragments of the mouse proot2(I) collagen gene linked to the Escherichia coli B-galactosidase or firefly luciferase genes to examine the activity of these promoters during development. A region of the mouse proot2(I) collagen promoter between -2,000 and +54 exhibited a pattern of/~-galactosidase activity during embryonic development that corresponded to the expression pattern of the endogenous proot2(I) collagen gene as determined by in situ hybridization. A similar pattern of activity was also observed with much smaller promoter fragments containing either 500 or 350 bp of upstream sequence relative to the start of transcription. Embryonic regions expressing high levels of/~-galactosidase activity included the bulbus arteriosus, valves of the developing heart, sclerotomes, meninges, limb buds, connective tissue fascia between muscle fibers, osteoblasts in newly formed bones, fibroblasts in tendons, periosteum, dermis, and peritoneal membranes. The pattern of fl-galactosidase activity was similar and included within the extracellular immunohistochemical localization pattern of transforming growth factor-ill (TGF-B1). region of the protx2(I) collagen promoter was previously shown to mediate the stimulatory effects of TGF-/~I on the proot2(I) collagen promoter in DNA transfection experiments with cultured fibroblasts. A construct containing this sequence tandemly repeated 5' to a very short ot2(I) collagen promoter (-40-+54) showed preferential activity in tail and skin of 4-wkold transgenic mice. Except for low expression of the transgene in bone, this pattern mimics the expression of the endogenous protx2(I) collagen gene. We propose the hypothesis that the tissue-specific expression of the protx2(I) collagen gene during embryogenesis is controlled by both TGF-B1 and cell-specific transcription factors; one of these could interact directly or indirectly with either the -315--284 or the -40-+54 segment.
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T YPE I collagen is the most abundant extracellular matrix protein in vertebrates and is a member of a family of multiple collagen types. It is a heterotrimer composed of two od(I) chains and one ot2(I) chain, which are coordinately regulated. Type I collagen is first detected at day eight during murine embryonic development (Adamson and Ayers, 1979; Leivo et al., 1980) and is crucial for complete vertebrate development (Adamson, 1982; Reddi et al., 1984) . Homozygous disruption of the protxl(I) collagen gene, caused by the integration of retroviral DNA into the first intron of the mouse gene, results in embryonic lethality at 12-13 d of gestation (Schnieke et al., 1983; Harbers et al., 1984) .
Expression of both prood(I) and protx2(I) collagen follows a distinct tissue-specific pattern. RNase protection assays show high levels of RNA encoding these polypeptides in bone, tendon, and skin, with much lower levels in other tissues (Slack et al., 1991; Goldberg et al., 1992) . The sequences responsible for this tissue-specific regulation have not been identified. However, several regions have been identified in the mouse procz2(I) and human, rat, and mouse protxl(I) collagen genes that regulate transcription Rossi et al., 1988; Karsenty et al., 1991; Ritzenthaler et al., 1991) . Within the 350-bp sequence upstream of the start of transcription of the mouse protx2(I) collagen gene, there are several functional cis-acting elements that stimulate proa2(I) gene transcription Hatamochi et al., 1988; Maity et al., 1988; Rossi et al., 1988) . A binding site for CCAAT transcription factor/nuclear factor-1 (CTF/NF-1) is present at -300. The -300 site mediates the effect of TGF-fll, which, when added to fibroblasts in culture, acts to stimulate the activity of a transfected tx2(1) promoter-CAT chimeric gene. Mutations in the NF-1 site abolish this TGF-B1 inducibility .
TGF-fll is a potent inducer of Type I collagen expression and may play an important role as a developmental regulator. TGF-fll and some of its related family members are expressed in restricted patterns during development (Akhurst et al., 1990) and several other family members such as activin and possibly bone morphogenetic factors may influence mesoderm formation during early stages of Xenopus development (Thomsen et al., 1990; Koster et al., 1991) .
Tissue culture transfection assays ) and transgenic mice (Khillan et al., 1986) have been used to identify the regions of the mouse o~2(1) collagen gene that confer tissue specificity. The ot2(I) promoter from -2,000 to +54 directed CAT reporter gene expression in a pattern mimicking that of the endogenous Type I collagen genes in adult mice (Khillan et al., 1986) . Sequences present in the first intron of the ot2(I) collagen gene which had previously been reported to contain an enhancer element were not required to direct tissue-specific expression (Khillan et al., 1986; Goldberg et al., 1992) . When the region from -350 to +54 of the proa2(l) collagen promoter was linked to CAT, transgenic mice displayed the same tissue-specific expression pattern, except that expression in the brain was also observed (Goldberg et ai., 1992) . Others have reported that the human procxl(I) collagen gene requires 2.3 kb of upstream promoter sequences to direct tissue-specific expression in transgenic mice (Slack et al., 1991) . Furthermore, the 5' flanking region of the prood(I) collagen gene between -3.5 and -2.3 kb has been implicated in high-level expression in osteoblasts (Pavlin et al., 1992) .
In this paper, we further define the ability of the procx2(I) collagen gene promoter to direct tissue-specific expression in transgenic mice. We have used the /3-galactosidase reporter gene to localize transgene expression during embryonic development. Through promoter deletions we show that 350 bp of promoter sequences linked to ~-galactosidase were sufficient to confer a very high degree of tissue and cell specificity. This pattern mimicked the distribution of endogenous procx2(I) collagen during development as determined by in situ hybridization and was similar to the immunohistochemical localization of TGF-/31. A region of the r collagen promoter from -315 to -284 which mediates the effects of TGF-/31 was tandemly repeated 5' to a short c~2(I) collagen promoter (-40-+54) linked to the firefly luciferase reporter gene. This chimeric gene showed a high degree of tissue-specific activity in transgenic animals.
Materials and Methods

Piasmid Constructions
Regions of the proa2(l) collagen promoter were inserted upstream of the translational start site of a/acZ expression vector (placF) (Mercer et al., 1991) which contains the mouse protamine gene sequences that supply an intron and polyadenylation signal (see Fig. 1 ). A 2,054-bp HindIII fragment (for -2,000/acZ) from pR40 was subcloned by blunt end ligation into the Sinai site of place A 554-bp XbaI to HindIH fragment from PR40 was made blunt using the Klenow enzyme and deoxynucleotide triphosphates; after addition of ~2~aI linkers this fragn~nt was ligated into the M~aI site of placF to create -500/acZ. A 404-bp Bgln to HindIII fragment, also from PR40 was similarly ligated into the X~I site of placF to create -350/acZ.
A segment consisting of four tandem copies of the pro~2(I) collagen promoter sequence from -315 to -284 inserted upstream of the -40-+54 proot2(I) collagen DNA segment was introduced into the polylinker region of the firefly luciferase vector (pA31uc) to create pLAG1 (Goldberg et al., 1992) . The pA31uc vector contains an SV-40 polyadenylation signal and splice sites 3' to the luciferase gene and a polyndenylation cassette 5' to the site in which the promoter region is inserted. In transfe~on studies, this 5'polyadenylation segment inhibits read-through transcription (Wood et al., 1989) .
Generation of Transgenic Mice
Transgenic mice were produced by pronuclear injection of gene construct into B6D2F2 fertilized eggs (Hogan et al., 1986) . The -2,000, -500, and -350/acZ plasmids were digested with Asp718 and HindIII, and pLAG1 was cleaved with AatlI and SacI to release the inserts from plasmid vector sequences (see Fig. 1 ). Founder mice carrying the introduced gene constructions were identified by Southern analysis of tail DNA (Southern, 1975) .
~-galactosidase and Luc~ferase Expression
/~-galactosidase activity was assayed in collagen-/acZ transgenic mouse lines by staining embryos with X-Gal using techniques previously described (Mercer et al., 1991) . Embryos were stained for 1-2 d. No additional staining appeared after 2 d. After staining, embryos were paraffin embedded. 6-pm-thick sections were counterstained with eosin.
To examine the expression of the luciferase reporter gene in LAG1 transgenic mice, representative organs from 4-wk-old animals were dissected from surrounding tissue, placed on dry ice, homogenized in a buffer conraining 100 mM Tris, pH 7.8, and 1 ram DTT, and microfuged. The supernatant was assayed for luciferase activity in the presence of excess D-luciferin (0.3 mg/ml), 15 mM MgSO4, 5 mM ATP, and 1 mM DTT. Known quantities of luciferase containing fibroblast cell extract were homogenized along with tissues from a normal mouse to determine whether these tissues contained inhibitors of luciferase activity. No inhibitors of luciferase activity were present in any of the mouse tissues. Measurements were taken using a Monolight 2010 luminometer. Protein levels were measured using the Bradford assay with BSA as standard (Bradford, 1976) . Results were expressed as luciferase light units per 1 mg of protein.
In situ Hybridization
Embryos isolated at 11.5-15.5 d posteoitum (Ell.5 to E15.5) were fixed in 10% formalin for 24 h or more (depending on size). After dehydration with increasing concentrations of ethanol, embryos were embedded in paraffin and sectioned onto silane-treated slides at a thickness of 6 ~an. A 200-bp PstI-EcoRI fragment coding for the COOH-terminal region of the rat proof2(1) collagen gene (pa2R2, kindly provided by Dr. David Rowe, University of Connecticut, Farmington, CT) was directionally cloned into Bluescript + (Stratagene Inc., La Jolla, CA) to give pKa2R2. Plasmids were linearized downstream of the inserted fragment with PstI and antisense riboprobes generated using T7 RNA polymerase. Similarly, plasmid pKa2R2 was digested with EcoRI, transcribed by T3 RNA polymerase to generate sense RNA. Probes were labeled with 3scxS-rUTP to a specific activity of 105 cpm/~,l. In situ hybridizations were performed as previously described (Wikinson et al., 1987) with the following modifications. Sections were postfixed in 4 % formaldehyde, treated with 40 ~tg/ml proteinase K for 7.5 rain, and treated with 0.1 M triethanolamine containing 0.25% acetic anhydride for 10 rain. Slides were heated for 2 rain at 98~ and cooled on ice before hybridization. The hybridization mix containing 50% formamide, 0.3 M NaC1, 1• Denhardt, 5 mM EDTA, 10 mM Tris, 10% dextran, 10 raM DTT, 10 mM NaHPO4, 500 ~,g/ml tRNA, 200/~g/ml calf thymus DNA, and the denatured probe was added to each slide and further incubated at 48~ overnight. Sections were treated with RNAse at 37~ for 30 rain using 20 #g/ml RNAse A and 1/tg/rnl RNAse T1. After washing, slides were dipped in a 50% mixture of NTB-2 (Eastman Kodak Co., Rochester, NY) and 0.6 M NH4Ac, further exposed at 4~ for 3-4 d for autoradiography, and subsequently developed. All sections were counter-stained with hematoxylin and photographed under darkground illumination.
Results
Generation of Transgenic Mice
Transgenic mouse lines were generated using the mouse oL2(I) collagen promoter-reporter gene constructions shown in Fig. 1 . Founder mice and progeny carrying the various gene constructions were identified. The number of copies of the transgenes in each line were characterized by Southern blot analysis (Table I) fused to the/acZ gene exhibited detectable/3-galactoside activity as assayed by X-gal staining of embryos. Three out of seven lines carrying the construction containing 500 bp upstream of the start of transcription expressed detectable /3-galactosidase activity. Three out of eight lines bearing the construct containing the -350-bp promoter, showed transgene expression. Variations were seen in the levels of transgene expression between lines with the same promoter construction and are likely influenced by the site of transgene integration. Overall, however, there was a remarkable similarity in the pattern of expression of/~-galactosidase in these different strains.
In contrast to the/acZ-containing strains, which were examined at various stages during embryonic development, transgenic mouse lines created with the luciferase reporter gene were tested by measuring luciferase activity in individual tissue of 4-wk-old founder mice (see Materials and Methods for details). At this age mice show higher levels of prot~l(I) collagen RNA than at later times (Slack et al., 1991) . Four of the five founders that were positive for the luciferase gene by Southern hybridization expressed the chimeric gene containing the tandemly repeated -315--284 sequence of the ct2(I) collagen promoter. This higher percentage of expression for mice carrying the luciferase transgene than for mice with a/~-galactosidase transgene can be accounted for by the much greater sensitivity of the assay for the luciferase enzyme.
t~2(I) Collagen LacZ Transgenes Direct 1Issue-specific Expression during Murine Development
The distinct transgene expression pattern directed by the construction harboring a -2,000-bp promoter is shown in whole embryos in Fig. 2 . At 9.5 d of embryonic development (E9.5; Fig. 2 A) transgene expression was first seen in the bulbus arteriosus, the most anterior segment of the tubular embryonic heart (Fig. 2 A) . 1 d later at E10.5 (Fig. 2 B) , a more pronounced X-gal staining appeared at the base of the limb buds and in the visceral arches. The upper ridge of the region of the head bordering the fourth ventricle and the upper region above the notochord also showed B-galactosidase expression. Staining in the telencephalic region was also seen in some lines. At E12.5 (Fig. 2 C) , flaring and indentation of the future digits occurred. A distinct radiating pattern of X-gal staining appeared in the developing digits. Marked staining was also visible in regions of the limbs closer to the body. These regions represent areas of early mesenchymal tissue condensation in forming bones and joints. A diffuse stain at the back of the head corresponds to staining in the developing meninges. Segmented expression in the sclerotomes was visible in the tail of the embryo; slightly rostral to this, the developing vertebrae show more intense expression. Transgene expression was also seen in the nasal region and forehead. At E13.5 (Fig. 2 D) digit formation was evident with transgene expression further demarcating this event.
There was transgene expression in a region surrounding the areas where the hair follicles of the face (vibrissae) appear. Other areas of transgene expression included the external portion of the developing ear (pinna), tail, skin, mesenchymal regions of the mandible, and both cranial and spinal meninges evident around the head and above the spinal cord. Fig. 2 E exemplifies the transgene expression that occurred in the tail and developing limbs of the -2,000 lacZ carrying mice at E15.5 (Fig. 2 E) .
Additional transgenic lines were generated containing truncations of the -2,000-bp promoter to determine whether smaller segments would confer similar patterns of expression. Two lines carrying the -500 lacZ construct and two lines carrying the -350/acZ construct showed/~-galactosidase expression similar to mice carrying the -2,000-bp promoter. Fig. 2, F and G show the pattern of staining in El0.5 and 12.5-d embryos carrying the -350-bp promoter. In a few other lines (not shown) B-galactosidase expression was restricted to regions such as the mandibular region, meninges, and sclerotomes. In three lines (one harboring the -2,000 lacZ construct and two with the -350 lacZ gene) small areas of promiscuous B-galactosidase activity occurred in the brain. Otherwise, no inappropriate transgene expression was observed.
Histological Localization of u2(I) Collagen LacZ Transgenes
As with/3-galactosidase staining in whole-mount embryos, the transgenic embryos carrying the -2,000, -500, and -3 5 0 a2(I) collagen promoter-lacZ construct showed striking similarities in ~3-galactosidase staining when further examined histologically (see Table II ). Staining clearly occurred in very discrete areas of tissues. The histological sections shown in Fig. 3 illustrate some examples of this exquisite cell specificity. At El0.5,/3-galactosidase expression was evident in the mesenchymal cells of the bulbus arteriosus (Fig. 3 A) . A day later in development, at Ell.5, /3-galactosidase expression was found in the sclerotomes (Fig. 3 B) . At this stage, staining in the heart was also restricted to cells of the endocardial cushion, a precursor to the developing coUagen-/acZ expression in adjacent chondrocytes in Meckels cartilage (mc). (E) E15.5 expression in the periosteum of the ribs (rb) (-2,000/acZ, line 30). (F) LacZ expression in the dermis (din) and underlying connective tissue (fib) in newborn mouse skin (-2,000 lacZ, line 30). Bars, 100 tLm. atrioventricular heart valves, as well as in the fibroblasts within the subendothelial layer of the endocardium but was absent in the myocardium itself (Fig. 3 C) .
At E12.5, transgene expression in cells of the heart valves and bulbus arteriosus was apparent (Fig. 3 D) . Expression in meningeal cells overlaying the brain (Fig. 3 E) and spinal cord was also seen. The specificity of the pattern of expression conferred by the o~2(I) collagen promoter was also demonstrated by X-gal staining which is restricted to the fibmblast-rich matrix surrounding the submandibular gland, and is not visible within the central parenchymal tissue (Fig.  3 F) .
At E15.5, when organogenesis is essentially complete, cell-specific transgene expression was again clearly appar- Fig. 4 A shows that the zone of densely arranged fibroblasts in tail tendon stained for/3-galactosidase. Transgene expression was also found solely in the fibroblasts of the endomysium surrounding individual muscle fibers (Fig. 4  B) . Fig. 4 C shows similar transgene expression in connective tissue cells interspersed between skeletal muscle fibers of the tongue. At E15.5, ossification is beginning to occur in certain bones such as the mandibular bone which showed one of the earliest intramembranous ossification regions. LacZ expression was seen in osteoblasts adjacent to newly formed bone matrix, but no expression was evident in the chondrocytes of Meckels cartilage (Fig. 4 D) . In the developing ribs, before the onset of endochondral ossification, transgene expression was found in the fibrous periosteum but not in the chondrocytes under the periosteum (Fig. 4 E) . Transgene expression in newborn mouse skin is shown in Fig. 4 F. ~galactosidase expression was found in the fibroblasts of the dermis and in cells of the subdermal connective tissue but was absent in the keratinized epithelial cells.
The discrete ceil-specific activity observed with the -2,000-bp promoter was exactly reproduced with the -500-and -300-bp promoter throughout embryonic development. Both the -500-and -350-bp promoters were active in osteoblasts in newly formed bones (data not shown). Very recently, we have also observed that the -500-bp promoter was active in odontoblasts (Table II) .
The very discrete, tissue-and cell-specific X-gal staining at different times of development is similar and is included in the patterns of extracellular TGF-~ expression during mouse development (Heine et al., 1987; Flanders et al., 1989; Akhurst et al., 1990; D'Souza et al., 1990 ; data not shown). For instance, an identical pattern of immunoreactive TGF-/$1 was found, in the developing cardiac cushion at Ell.5 (see Fig. 3 B for transgene expression) . A similar discrete localization of TGF-/~I was also found in sclerotomes at Ell.5 (Heine et al., 1987 ; data not shown). 'I'GF-/31 is present in the extracellular matrix surrounding meningeal fibroblasts in an identical pattern as was seen for fl-gaiactosidase in Fig. 3 E. Other examples of this striking similarity between TGF-B1 localization and X-gal staining are in the connective tissue of fascia separating groups of myotubes (Fig. 4, B and C) and in the newly formed ossification centers (Fig. 4 D) (Heine et al., 1987; R. D'Souza, unpublished observation) .
The Expression Pattern of the a2(I) CoUagen-LacZ Transgenes Mimics That of the Endogenous pro~2(I) Collagen Gene
Expression of the endogenous mouse ~2(I) collagen gene was examined by in situ hybridization of embryos using an antisense rat pro~2(I) collagen RNA probe. The pattern of embryonic proot2(I) collagen RNA was identical to the pattern of procd(I) collagen RNA (Cheah et al., 1991 and data not shown). Expression of the fl-galactosidase transgene was very similar to the pattern of expression of the endogenous gene, although in some areas, such as the peritoneal membranes, X-gai staining was not as uniform as the pattern that was seen by in situ hybridization. Fig. 5 shows representative examples that highlight the similarities between the tissuespecific expression of the endogenous proa2(I) collagen gene and that of the transgenic construction. At Ell, the in situ hybridizations showed discrete signals of expression in the sclerotomal cells (Fig. 5 A) , in a similar yet broader pattern than the X-gal staining shown in Fig. 3 B. Fig. 5 B shows high signal intensity in meningeal fibroblasts at E12.5 in a pattern that mimics transgene expression shown in Fig. 3 E. Similarly, hybridization in fibroblasts within the connective tissue surrounding the muscles of the tongue (Fig. 5 C) at E14.5 was very similar to the X-gal staining of Fig. 4 C. At this stage of development, periosteal cells surrounding the developing ribs show a strong hybridization signal (Fig. 5 D) that, again was similar to the staining in transgenic embryos (Fig. 4 E) , and hybridization occurred in fully differentiated osteoblasts within the mandible (data not shown), like that seen for fl-galactosidase staining (Fig. 4 D) .
A Region of the ~2(I) Collagen Promoter from -315 to -284 Tandemly repeated Upstream of a Minimal Promoter Can Direct Luciferase Expression in a tissue-Specific Manner
Previous transient expression studies using cultured fibroblasts had indicated that a region within the ot2(I) collagen promoter between -315 and -284 mediates the increased activity of a transfected ~2(I) collagen promoter in response to TGF-~I . To examine the possible role of this region in directing the tissue-specific expression of the ot2(I) collagen promoter, tandem copies of this sequence were inserted upstream of a very short a2(I) collagen promoter (-40-+54) linked to the highly sensitive firefly luciferase reporter gene (Fig. 1) . The short promoter contains a TATA dement to which the general transcription factor TFIID pre- sumably binds. In transient expression experiments of fibroblasts in culture, the -40-+54 segment itself is only 1% as active as the -350-bp promoter (Goldberg et al., 1992) . Mice, positive for the transgene, were killed at 4 wk of age and assayed for luciferase activity in various tissues (Table HI) . In all four founders, transgene expression was highest in the tail. Expression in the skin, though more variable, was also elevated. However, the expression of the transgene did not mimic the high level of endogenous Type I collagen RNA found in calvaria. This may suggest that a promoter element necessary for high expression of the transgene in bone is absent from this construction. Tissues that have very low levels of endogenous t~2(I) collagen RNA, such as liver, lung, and kidney (Goldberg et al., 1992) , also showed very low levels of luciferase activity. Moderate to low levels of luciferase activities were found in brain in three founders and in several other tissues in some founders. These activities could be attributed to the integration site of the transgene since none were consistent across all lines. These results suggest that the -315--284 sequence plays an important role in mediating the activity of the o~2(I) collagen gene in skin and tail. The lack of high level expression of LAG1 in bone warrants further study.
Discussion
Expression of the Type I collagen genes follows a specific and discrete pattern. The present study was performed to examine in detail the tissue-specific activity of promoter segments of the gene for the mouse oL2 chain of Type I collagen during embryonic development and to determine which minimal sequences were capable of conferring this discrete tissue-specific activity. The following three major conclusions can be drawn from this study: First, although the activity of the -350-bp promoter was generally less than that of the -2,000-bp promoter, the pattern of expression of the -350-bp promoter-/acZ chimeric gene was the same as that of the -2,0O0-bp promoter. Both clearly mimicked the expression of the endogenous gene during embryonic development. Hence, the segment between -350 and +54 of the mouse ot2(l) collagen promoter contained sufficient information to confer correct temporal and spatial expression during embryonic development to a reporter gene. This expression was also remarkably cell type-specific, e.g., when the proa2(I) collagen gene was transcriptionally active in a tissue such as muscle, transgene expression was limited to the fibroblasts in the endomysium surrounding the muscle fibers. Since the/acZ promoter construction containing the -350-+54 segment was also active in osteoblasts, sufficient information existed in this segment to direct bone-specific transgene expression.
The spatial and temporal activity of the proa2(I) collagen promoter resembled closely the extracellular immunohistochemical localization of TGF-/31 during embryonic development (Heine et al., 1987; Flanders et al., 1989) . It is likely that regardless of the exact location of the ceils where TGF-/31 is synthesized, its extracellular localization is critical for its function during embryonic development. Furthermore, several lines of evidence suggest that control of the amounts of active TGF-/31 in the extracellular matrix available for interaction with its signaling receptors is a highly regulated process (for review see Massague, 1990) .
Second, when a segment of the a2(I) collagen promoter between -315 and -284 was tandemly repeated upstream of a very short ot2(I) collagen promoter (-40-+54), itself linked to the luciferase gene, this chimeric gene displayed a high degree of tissue-specific expression in 4-wk-old founder mice. It should be noted, however, that this construct was only poorly expressed in bones, suggesting that an additional sequence may be needed to determine the correct activity of this promoter in osteoblasts. Since the -350/acZ chimeric gene was active in osteoblasts, it is likely that such a putative bone-specific element would be located within this -350-bp segment. The promoter with the tandemly repeated -315--284 sequence was much less active than the -2,000-and -350-bp promoters and we were unable to examine its activity in transgenic embryos when it was linked to a/~-galactosidase reporter gene (data not shown). Our results, however, suggest an important role for either the -315--284 sequence or the -40-+54 sequence or both in conferring tissue specificity. It is clear that other cis-acting elements exist within the -350-bp proximal promoter and probably outside of it which contribute to the overall strength of the promoter.
The observed correlation between the tissue-specific spatial and temporal activity of the a2(I) collagen promoter and the presence of immunoreactive extracellular TGF-~ is not simply coincidental but suggests a role for TGF-/~I in the tissue-and cell-specific activity of the proot2(I) collagen gene during embryonic development. Several other observations support this hypothesis. TGF-/31 increases the steadystate levels of type I collagen RNAs in fibroblasts in culture (Raghow et al., 1987; Ignotz et al., 1987; Massague et al., 1990) . When injected subcutaneously in newborn mice, TGF-/~I also increases the accumulation of type I collagen at the site of injection (Roberts et al., 1986) . In addition, TGF-/31 was shown to stimulate the activity of a -2,000-bp mouse a2(I) collagen promoter chimeric genes in transient expression experiments of fibroblasts (Rosa et al., 1988) . The same -315--284 segment of the oe20) collagen promoter that was used in a short promoter construction conserving a high degree of tissue specificity in transgenic mice, could mediate the effects of TGF-/31 on the activation of a transfected proot2(I) collagen promoter .
TGF-~I is a member of a family of polypeptides of which several have important roles in early embryonic decisions. Both activins (Thomsen et al., 1990) and TGF-/32 (Rosa et al., 1988) have been shown to induce the synthesis of mesodermic markers in early frog embryos. The temporal and spatial correlation between the activity of the a2(I) collagen promoter-/acZ transgene, the expression of endogenous Type I collagen genes, and the extracellular localization of TGF-/31 during embryonic development in the mouse (Heine et al., 1987; Flanders et al., 1989; Heine et al., 1990 ; R. D'Souza, unpublished results), together with the ability of TGF-/31 to activate the ct2(I) collagen promoter in fibroblasts in culture, suggest that Type I collagen genes may constitute an important end point in the pathways controlled by TGF-/31. Type I collagen is a major structural protein during embryonic development. Along with Type I collagen proteins, other collagen proteins, metalloproteinases, and protease inhibitors are synthesized during fibroblast differentiation. The synthesis of these other components is also controlled by TGF-/31 in fibroblasts in culture (for review see . Our working model is that the tissue-specific activity of the Type I collagen genes during embryonic development would be controlled both by TGF-/31 and by cell-specific transcription factors that include one which would bind, directly or indirectly, either to the -315--284 sequence or to the -40-+54 segment. This factor still needs to be identified. Our experiments also raise the question whether TGF-/31 induces the differentiation of fibroblasts from more primitive mesenchymal ceils during embryonic development. Since in many tissues the patterns of immunohistochemical localization of TGF-~2 and TGF-~3 as well as the distribution of the corresponding transcripts overlap with those of TGF-/31 (Petton et al., 1990; Pelton et al., 1991; Schmid et al., 1991) , it is possible that these factors also act in stimulating fibroblast differentiation and Type I collagen expression.
It is difficult to estimate the overall level of expression of the/acZ transgenes driven by prot~2(I) collagen promoters. Indeed, the observed activity of/~-galactosidase is dependent on the rate of synthesis oflacZ mRNA but also on its stability and on the stability of the E. coli #-galactosidase itself. Furthermore since X-gal staining was performed on whole embryos estimation of the levels of transgene expression, especially in less accessible tissues of older embryos, may not be accurately represented. We believe, nonetheless, that expression of the transgenes that were tested was weaker than that of the endogenous proot2(I) collagen gene. Transfections of DNA into fibroblasts in culture using promoter constructions linked to either the CAT or the firefly luciferase gene have indicated that even the a20) collagen promoter constructions containing -2,000 bp were considerably weaker than similar al(I) collagen promoters, long-terminal repeat viral promoters, or a SV-40 early promoter Goldberg et al., 1992) . Therefore, it is possible that the proximal 2,000 bp of the t~2(I) collagen promoter, though tissue specific, lack appropriate enhancer regions necessary to direct high-level expression that are located elsewhere. A locus control region located ~40 kb 5' from the/3-globin gene, confers high-level tissue-specific transgene expression which is independent of the site of integration (Grosveld et al., 1987) .
Our results in transgenic mice establish the very high degree of tissue and cell specificity of Type I collagen promoters. TGF-#5'I plays a major role in eliciting the excessive accumulation of extraeellular matrix components, including Type I collagen, in certain animal models with fibrotic diseases (Border et al., 1990 ). Hence, it is possible that the same mechanisms which control the synthesis of fibroblastspecific extracellular matrix components during embryonic development could also be abnormally activated in fibrotic lesions.
